Table 1 Comparison between the study groups (I and II) as regards demographic, clinical, and laboratory data at baseline
From: Diagnostic accuracy of serum endothelin-1 in patients with HCC on top of liver cirrhosis
Group I n = 30 | Group II n = 30 | P value | |
|---|---|---|---|
HBV | 6.7% | 0.0% | 0.31 |
HCV | 80.0% | 80.0% | 1.00 |
Unknown | 13.3% | 20.0% | 0.62 |
DM | 16.7% | 13.4% | 0.76 |
Hypertension | 16.7% | 23.4% | 0.67 |
History of ascites | 70.0% | 50.0% | 0.36 |
History of lower limb edema | 80.0% | 50.0% | 0.16 |
Abdominal pain | 46.7% | 10.0% | 0.06 |
Abdominal tenderness | 10.0% | 10.0% | 1.00 |
Bleeding tendency | 56.7% | 53.3% | 0.71 |
History of GIT bleeding | 36.7% | 40.0% | 0.79 |
History of hepatic encephalopathy | 53.3% | 46.7% | 0.61 |
Clinical presence of hepatic encephalopathy | 73.3% | 60.0% | 0.71 |
Hb (mean ± SD) | 10.82 ± 2.43 | 9.16 ± 2.85 | 0.09 |
WBCs (mean ± SD) | 7.70 ± 3.76 | 6.25 ± 4.14 | 0.23 |
Platelets (mean ± SD) | 143.40 ± 67.63 | 93.70 ± 80.59 | 0.03 |
Albumin (g/dl) | 2.8 ± 0.7 | 2.6 ± 0.5 | 0.10 |
Total bilirubin (mg/dl) | 3.14 ± 2.9 | 3.5 ± 3.7 | 0.61 |
ALT (IU/l) | 68.3 ± 20.2 | 65.5 ± 20 | 0.21 |
AST (IU/l) | 54.2 ± 15.8 | 48.1 ± 8 | 0.18 |
PT (s) | 16.8 ± 6.7 | 16.6 ± 1.8 | 0.83 |
Creatinine (mg/dl) | 1.6 ± 0.9 | 1.8 ± 0.9 | 0.71 |
P.V.T | 26.7% | 0.0% | NA |
Metastasis | 0.0% | 0.0% | NA |